Eligibility for vericiguat in a real‐world, contemporary heart failure population
Eligibility for vericiguat in a real‐world, contemporary heart failure population
About this item
Full title
Author / Creator
Vergaro, Giuseppe , Aimo, Alberto , Gentile, Francesco , Mandoli, Giulia Elena , Focardi, Marta , Castiglione, Vincenzo , Giannoni, Alberto , Panichella, Giorgia , Fornaro, Alessandra , Carluccio, Erberto , Liga, Riccardo , Salatin, Mattia , Passino, Claudio , Piepoli, Massimo F. , Cameli, Matteo , Cappelli, Francesco , Di Mario, Carlo and Emdin, Michele
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Aims
Vericiguat is a soluble guanylate cyclase stimulator and improves survival in patients with heart failure (HF) with reduced ejection fraction (HFrEF) and an increased risk of decompensation. As real‐world data on how many patients could be eligible for vericiguat therapy derive from outdated registries, we aimed to assess eligibility in a p...
Alternative Titles
Full title
Eligibility for vericiguat in a real‐world, contemporary heart failure population
Authors, Artists and Contributors
Author / Creator
Aimo, Alberto
Gentile, Francesco
Mandoli, Giulia Elena
Focardi, Marta
Castiglione, Vincenzo
Giannoni, Alberto
Panichella, Giorgia
Fornaro, Alessandra
Carluccio, Erberto
Liga, Riccardo
Salatin, Mattia
Passino, Claudio
Piepoli, Massimo F.
Cameli, Matteo
Cappelli, Francesco
Di Mario, Carlo
Emdin, Michele
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e4c835deed324142b911545a11c71cdf
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e4c835deed324142b911545a11c71cdf
Other Identifiers
ISSN
2055-5822
E-ISSN
2055-5822
DOI
10.1002/ehf2.14767
